12 employees
Gregor Diagnostics is a molecular diagnostics company developing a screening test technology for prostate cancer.
2016
$900K
from 3 investors over 3 rounds
Gregor Diagnostics raised $900K on July 10, 2018
Investors: Green Park & Golf Ventures and First Round Capital
Gregor Diagnostics raised $30K on August 31, 2017
Investors: Health Wildcatters